Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Peptide Antibiotics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Peptide Antibioticsmarket, defines the market attractiveness level of Peptide Antibiotics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Peptide Antibiotics industry, describes the types of Peptide Antibiotics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Peptide Antibiotics market and the development prospects and opportunities of Peptide Antibiotics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Peptide Antibiotics market in Chapter 13.
By Player:
AMP Therapeutics
Madam Therapeutics
Eli Lilly
Hospira
Pfizer
Theravance
Phosphagenics
Novartis
Kasten
Pacgen Life Science Corporation
Savara Pharmaceuticals
GlaxoSmithKline
Vicuron Pharmaceuticals
By Type:
Ribosomal Synthesized Peptide Antibiotics
Non-Ribosomally Synthesized Peptide Antibiotics
By End-User:
Pharma & Healthcare
Food Industry
Commodities
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Peptide Antibiotics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Peptide Antibiotics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Peptide Antibiotics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Peptide Antibiotics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Peptide Antibiotics Market Analysis and Outlook to 2022
-
7.1 Global Peptide Antibiotics Consumption (2017-2022)
-
7.2 United States Peptide Antibiotics Consumption (2017-2022)
-
7.3 Europe Peptide Antibiotics Consumption (2017-2022)
-
7.4 China Peptide Antibiotics Consumption (2017-2022)
-
7.5 Japan Peptide Antibiotics Consumption (2017-2022)
-
7.6 India Peptide Antibiotics Consumption (2017-2022)
-
7.7 South Korea Peptide Antibiotics Consumption (2017-2022)
8 Region and Country-wise Peptide Antibiotics Market Analysis and Outlook to 2028
-
8.1 Global Peptide Antibiotics Consumption Forecast (2022-2028)
-
8.2 United States Peptide Antibiotics Consumption Forecast (2022-2028)
-
8.3 Europe Peptide Antibiotics Consumption Forecast (2022-2028)
-
8.4 China Peptide Antibiotics Consumption Forecast (2022-2028)
-
8.5 Japan Peptide Antibiotics Consumption Forecast (2022-2028)
-
8.6 India Peptide Antibiotics Consumption Forecast (2022-2028)
-
8.7 South Korea Peptide Antibiotics Consumption Forecast (2022-2028)
9 Global Peptide Antibiotics Market Outlook by Types and Applications to 2022
-
9.1 Global Peptide Antibiotics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Ribosomal Synthesized Peptide Antibiotics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Non-Ribosomally Synthesized Peptide Antibiotics Consumption and Growth Rate (2017-2022)
-
9.2 Global Peptide Antibiotics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Pharma & Healthcare Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Food Industry Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Commodities Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Peptide Antibiotics Market Outlook by Types and Applications to 2028
-
10.1 Global Peptide Antibiotics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Ribosomal Synthesized Peptide Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Non-Ribosomally Synthesized Peptide Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Peptide Antibiotics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Pharma & Healthcare Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Food Industry Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Commodities Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Peptide Antibiotics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Peptide Antibiotics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Peptide Antibiotics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Peptide Antibiotics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Peptide Antibiotics Market Competitive Analysis
-
14.1 AMP Therapeutics
-
14.1.1 AMP Therapeutics Company Details
-
14.1.2 AMP Therapeutics Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AMP Therapeutics Peptide Antibiotics Product and Service
-
14.2 Madam Therapeutics
-
14.2.1 Madam Therapeutics Company Details
-
14.2.2 Madam Therapeutics Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Madam Therapeutics Peptide Antibiotics Product and Service
-
14.3 Eli Lilly
-
14.3.1 Eli Lilly Company Details
-
14.3.2 Eli Lilly Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Eli Lilly Peptide Antibiotics Product and Service
-
14.4 Hospira
-
14.4.1 Hospira Company Details
-
14.4.2 Hospira Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Hospira Peptide Antibiotics Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Peptide Antibiotics Product and Service
-
14.6 Theravance
-
14.6.1 Theravance Company Details
-
14.6.2 Theravance Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Theravance Peptide Antibiotics Product and Service
-
14.7 Phosphagenics
-
14.7.1 Phosphagenics Company Details
-
14.7.2 Phosphagenics Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Phosphagenics Peptide Antibiotics Product and Service
-
14.8 Novartis
-
14.8.1 Novartis Company Details
-
14.8.2 Novartis Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Novartis Peptide Antibiotics Product and Service
-
14.9 Kasten
-
14.9.1 Kasten Company Details
-
14.9.2 Kasten Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Kasten Peptide Antibiotics Product and Service
-
14.10 Pacgen Life Science Corporation
-
14.10.1 Pacgen Life Science Corporation Company Details
-
14.10.2 Pacgen Life Science Corporation Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Pacgen Life Science Corporation Peptide Antibiotics Product and Service
-
14.11 Savara Pharmaceuticals
-
14.11.1 Savara Pharmaceuticals Company Details
-
14.11.2 Savara Pharmaceuticals Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Savara Pharmaceuticals Peptide Antibiotics Product and Service
-
14.12 GlaxoSmithKline
-
14.12.1 GlaxoSmithKline Company Details
-
14.12.2 GlaxoSmithKline Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 GlaxoSmithKline Peptide Antibiotics Product and Service
-
14.13 Vicuron Pharmaceuticals
-
14.13.1 Vicuron Pharmaceuticals Company Details
-
14.13.2 Vicuron Pharmaceuticals Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Vicuron Pharmaceuticals Peptide Antibiotics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Peptide Antibiotics
-
Figure Peptide Antibiotics Picture
-
Table Global Peptide Antibiotics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Peptide Antibiotics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Peptide Antibiotics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Peptide Antibiotics Consumption by Country (2017-2022)
-
Figure United States Peptide Antibiotics Consumption and Growth Rate (2017-2022)
-
Table Europe Peptide Antibiotics Consumption and Growth Rate (2017-2022)
-
Figure China Peptide Antibiotics Consumption and Growth Rate (2017-2022)
-
Figure Japan Peptide Antibiotics Consumption and Growth Rate (2017-2022)
-
Figure India Peptide Antibiotics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Peptide Antibiotics Consumption and Growth Rate (2017-2022)
-
Figure Global Peptide Antibiotics Consumption Forecast by Country (2022-2028)
-
Figure United States Peptide Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Peptide Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Peptide Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Peptide Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Peptide Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Peptide Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ribosomal Synthesized Peptide Antibiotics Consumption and Growth Rate (2017-2022)
-
Figure Global Non-Ribosomally Synthesized Peptide Antibiotics Consumption and Growth Rate (2017-2022)
-
Figure Global Pharma & Healthcare Consumption and Growth Rate (2017-2022)
-
Figure Global Food Industry Consumption and Growth Rate (2017-2022)
-
Figure Global Commodities Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Ribosomal Synthesized Peptide Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-Ribosomally Synthesized Peptide Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharma & Healthcare Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Food Industry Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Commodities Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Peptide Antibiotics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Peptide Antibiotics Export by Region (Top 5 Countries) (2017-2028)
-
Table AMP Therapeutics (Foundation Year, Company Profile and etc.)
-
Table AMP Therapeutics Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AMP Therapeutics Peptide Antibiotics Product and Service
-
Table Madam Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Madam Therapeutics Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Madam Therapeutics Peptide Antibiotics Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Peptide Antibiotics Product and Service
-
Table Hospira (Foundation Year, Company Profile and etc.)
-
Table Hospira Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hospira Peptide Antibiotics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Peptide Antibiotics Product and Service
-
Table Theravance (Foundation Year, Company Profile and etc.)
-
Table Theravance Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Theravance Peptide Antibiotics Product and Service
-
Table Phosphagenics (Foundation Year, Company Profile and etc.)
-
Table Phosphagenics Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Phosphagenics Peptide Antibiotics Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Peptide Antibiotics Product and Service
-
Table Kasten (Foundation Year, Company Profile and etc.)
-
Table Kasten Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kasten Peptide Antibiotics Product and Service
-
Table Pacgen Life Science Corporation (Foundation Year, Company Profile and etc.)
-
Table Pacgen Life Science Corporation Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pacgen Life Science Corporation Peptide Antibiotics Product and Service
-
Table Savara Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Savara Pharmaceuticals Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Savara Pharmaceuticals Peptide Antibiotics Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Peptide Antibiotics Product and Service
-
Table Vicuron Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Vicuron Pharmaceuticals Peptide Antibiotics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vicuron Pharmaceuticals Peptide Antibiotics Product and Service
-
